Interesting Stocks
Collapse
X
-
My only remaining position in these now is in QBTS (and perhaps MSFT, if you count that as a quantum play). I had some SKYT as well but sold it at 34, thinking 35 was the max it would trade at, due to the $35 acquisition price.... of course part of the purchase was in IONQ, so there is upside still with SKYT. I want to hold QBTS until the market starts talking trillions for some of these quantum chip companies (besides MSFT and GOOG). It could be my lottery ticket! Timeline should be ~3-5 years before we know which one(s) are the actual winner(s) in the race to own the Google/ChatGPT of quantum tech application. It's a fact that they're just getting started with this tech, and it will be HUGE very soon. My guess is the winner(s) gets bought by either MSFT, GOOG, or xAI for upwards of $500B in cash and stock.
-
-
QBTS, IONQ, SKYT all made nice moves this week - hope you're still in one/some of these quantum plays - US gov't is now on board and supporting this tech, so a healthy investment in these is starting to really pay off!Originally posted by BlueWolf View PostExcellent! I’ve been watching QBTS closely. I saw it soaring last week. All quantum stocks soared last week including another I’m watching, IONQ.
QBTS was setup with a really nice pattern for entry around the 12th, but I didn’t pull the trigger. I don’t know why because I like the stock and I think it has big long term potential. Glad you got in at a good point, though. I’d definitely hold that one.
Leave a comment:
-
-
Yeah, that's what I figured. Question is, can they make back a half-billion in R&D costs by selling therapy treatments? Without seeing what the market is willing to pay for this stuff, it's hard to justify a $4 share price, let alone $14. Maybe it works out, or approval gives this stock a quick bump up and a chance to get out with a few bucks in profit, but I think it's looking like a long shot to become a viable ongoing business (as most pre-approval drug companies are).
Leave a comment:
-
-
They’re pre-revenue. They are working on getting FDA approval for their treatment.Originally posted by jiesen View PostThe chart for CMPS is impressive, in that it went from under $4 to over $10 in a year. But the numbers on their books don't make any sense to me... They spend $100M+ every year (half on Sales/admin), but have 0 revenues. Maybe they're just getting started, but with no sales numbers to look at, I don't know if $10/shr is good or bad. Are they selling the therapy, or just selling stock?
Leave a comment:
-
-
The chart for CMPS is impressive, in that it went from under $4 to over $10 in a year. But the numbers on their books don't make any sense to me... They spend $100M+ every year (half on Sales/admin), but have 0 revenues. Maybe they're just getting started, but with no sales numbers to look at, I don't know if $10/shr is good or bad. Are they selling the therapy, or just selling stock?
Leave a comment:
-
-
Came across another fascinating stock this week, COMPASS Pathways (CMPS). This one is a super speculator. They’re pre revenue, but they’re developing psilocybin therapy for treatment-resistant depression. Shades of Timothy Leary. I’m gonna have to keep an eye on this one just to see what happens here. I’m not saying this is an investment opportunity yet, but it’ll be fun to follow.
Leave a comment:
-
-
Here’s an another interesting company, Fauna Robotics, making humanoid robots. They just got gobbled up by Amazon.
Leave a comment:
-
-
Looks like IONQ is acquiring SKYT. Should be good for both companies.
Leave a comment:
-
-
I own both SKYT and QBTS, and am a big proponent of quantum computing tech. There is definitely the potential for lots of money to be made with some of these stocks. Hopefully, at least one of them will be either SKYT or QBTS! (I'm in on both of these at around $7)
Leave a comment:
-
-
Oh, I forgot to mention my interest in quantum computing technology stocks. There are a few publicly traded, pure plays right now including ARQQ, IONQ, QBTS, QUBT, and RGTI. At this point these are all pretty much pre-revenue or light-revenue, technology plays. There are also some big players in this space including AMZN, GOOG, IBM, INTC, and MSFT. I currently hold several of these, in part because of their involvement in quantum computing. MSFT, in particular, has had some important breakthroughs in quantum computing. Finally, there are fabrication companies like SKYT that have high exposure in quantum computing.
Based on technology and momentum, I like IONQ and RGTI the most right now followed by SKYT and QBTS. I’d be curious about any of your thoughts on this technology, these companies, or any other companies you might know about in this field.
Leave a comment:
-
-
One stock I’m obsessing over right now is ASML. Their technology is otherworldly. Nobody else comes close when it comes to chip fabrication. I used to own it, but I sold it off way too early. Now I can’t get an entry because it just keeps blowing up and I don’t want to chase it. It was basing in December, which was the perfect time to buy it. Did I buy it, though? Noooooo. Now all I can do is complain about it and hope for a pull back.
I’m kind of liking GCT the more I look at it too. I’m not in love as much as I am with ASML, but it looks solid. It’s been a finalist a couple of times in Mr. Market’s scans, and it’s basing right now on its chart. Multiples are creeping up, but it still has a decent valuation. I might take a shot on this one.
Leave a comment:
-
-
It actually hit 20% today, so I’ll be trail stopping it from here on out. I like the company, though, so I may sell some shares and then hold on to the rest in my long term portfolio.Originally posted by BlueWolf View PostFound another stock that intrigues: Credo Technology Group Holding Ltd (NASDAQ:CRDO). They’re basically a data center infrastructure company. They caught my attention because of their rapid revenue growth, going from $193M to $796 in the TTM in just two years. The fact that their cash flow went positive in 2025 with their net income looking to take another big bump in 2026 doesn’t hurt. Chartwise, it’s pulled back from its all time high of $213 to around $130, but it’s sitting at a support level. The downside: The multiples are definitely reflective of a growth company, so it’s pricey and their fate is tied to the AI industry. If the bubble burst, they’ll deflate with the rest of the industry. Still, I am intrigued, so I took a position today. Looking for a 20% to 40% gain with a stop around $122, which represents a 6% loss. I’ll start trail stopping it if it reaches 20%. Risk/reward of 3+:1 is reasonable, so that’s why I took a shot. I’m not super confident, so it’s only a normal size position.
Leave a comment:
-
-
Found another stock that intrigues: Credo Technology Group Holding Ltd (NASDAQ:CRDO). They’re basically a data center infrastructure company. They caught my attention because of their rapid revenue growth, going from $193M to $796 in the TTM in just two years. The fact that their cash flow went positive in 2025 with their net income looking to take another big bump in 2026 doesn’t hurt. Chartwise, it’s pulled back from its all time high of $213 to around $130, but it’s sitting at a support level. The downside: The multiples are definitely reflective of a growth company, so it’s pricey and their fate is tied to the AI industry. If the bubble burst, they’ll deflate with the rest of the industry. Still, I am intrigued, so I took a position today. Looking for a 20% to 40% gain with a stop around $122, which represents a 6% loss. I’ll start trail stopping it if it reaches 20%. Risk/reward of 3+:1 is reasonable, so that’s why I took a shot. I’m not super confident, so it’s only a normal size position.
Leave a comment:
-

Leave a comment: